Stocktoria

Raphael Pharmaceutical Inc. RAPH

OTC · stock · Medicinal Chemicals & Botanical Products · website · IPO 2022-08-23

Raphael Pharmaceutical Inc. statistics & valuation

Market cap$28.2M

Market cap as of 2026-07-01. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
202020212022202320242025
Operating margin (%)
202020212022202320242025
Return on equity (%)
-1268.80% -3167.90% -1256.10% 202020212022202320242025
Shares outstanding
9.5M 13.0M 15.6M 18.5M 18.7M 20.2M 202020212022202320242025
Net debt ($)
202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
-222.30% -384.80% -1008.40% -562.30% -5625.90% -2413.20% 202020212022202320242025
Free cash flow margin (%)
202020212022202320242025
Debt / equity (×)
202020212022202320242025
EPS ($)
$0.14 $0.23 $0.08 $0.08 $0.07 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

Raphael Pharmaceutical Inc. trades at about 20× earnings — above its 10-year norm (10-year range 4.8×–20×, median 12.5×).

4.8× 20×

Shaded band = 10-year range (4.8×–20×); dot = today's 20×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Return on assets-2413.2%-5625.9%-562.3%-1008.4%-384.8%-222.3%
Return on equity89.3%204.7%-1256.1%-3167.9%-1268.8%1669.8%
Current ratio0.030.031.801.461.440.88

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.